Literature DB >> 19776209

The mammalian ovary from genesis to revelation.

Mark A Edson1, Ankur K Nagaraja, Martin M Matzuk.   

Abstract

Two major functions of the mammalian ovary are the production of germ cells (oocytes), which allow continuation of the species, and the generation of bioactive molecules, primarily steroids (mainly estrogens and progestins) and peptide growth factors, which are critical for ovarian function, regulation of the hypothalamic-pituitary-ovarian axis, and development of secondary sex characteristics. The female germline is created during embryogenesis when the precursors of primordial germ cells differentiate from somatic lineages of the embryo and take a unique route to reach the urogenital ridge. This undifferentiated gonad will differentiate along a female pathway, and the newly formed oocytes will proliferate and subsequently enter meiosis. At this point, the oocyte has two alternative fates: die, a common destiny of millions of oocytes, or be fertilized, a fate of at most approximately 100 oocytes, depending on the species. At every step from germline development and ovary formation to oogenesis and ovarian development and differentiation, there are coordinated interactions of hundreds of proteins and small RNAs. These studies have helped reproductive biologists to understand not only the normal functioning of the ovary but also the pathophysiology and genetics of diseases such as infertility and ovarian cancer. Over the last two decades, parallel progress has been made in the assisted reproductive technology clinic including better hormonal preparations, prenatal genetic testing, and optimal oocyte and embryo analysis and cryopreservation. Clearly, we have learned much about the mammalian ovary and manipulating its most important cargo, the oocyte, since the birth of Louise Brown over 30 yr ago.

Entities:  

Mesh:

Year:  2009        PMID: 19776209      PMCID: PMC2761115          DOI: 10.1210/er.2009-0012

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  816 in total

1.  Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a.

Authors:  Diego H Castrillon; Lili Miao; Ramya Kollipara; James W Horner; Ronald A DePinho
Journal:  Science       Date:  2003-07-11       Impact factor: 47.728

Review 2.  Analysis of oocyte physiology to improve cryopreservation procedures.

Authors:  David K Gardner; Courtney B Sheehan; Laura Rienzi; Mandy Katz-Jaffe; Mark G Larman
Journal:  Theriogenology       Date:  2006-10-17       Impact factor: 2.740

3.  Requirement of tissue-selective TBP-associated factor TAFII105 in ovarian development.

Authors:  R N Freiman; S R Albright; S Zheng; W C Sha; R E Hammer; R Tjian
Journal:  Science       Date:  2001-09-14       Impact factor: 47.728

4.  Morphology of oocyte and follicle destruction by polycyclic aromatic hydrocarbons in mice.

Authors:  D R Mattison
Journal:  Toxicol Appl Pharmacol       Date:  1980-04       Impact factor: 4.219

5.  Male-to-female sex reversal in mice lacking fibroblast growth factor 9.

Authors:  J S Colvin; R P Green; J Schmahl; B Capel; D M Ornitz
Journal:  Cell       Date:  2001-03-23       Impact factor: 41.582

6.  R-spondin1 is a high affinity ligand for LRP6 and induces LRP6 phosphorylation and beta-catenin signaling.

Authors:  Qiou Wei; Chika Yokota; Mikhail V Semenov; Brad Doble; Jim Woodgett; Xi He
Journal:  J Biol Chem       Date:  2007-03-30       Impact factor: 5.157

7.  Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice.

Authors:  T R Kumar; Y Wang; M M Matzuk
Journal:  Endocrinology       Date:  1996-10       Impact factor: 4.736

8.  Hormonal regulation of apoptosis in early antral follicles: follicle-stimulating hormone as a major survival factor.

Authors:  S Y Chun; K M Eisenhauer; S Minami; H Billig; E Perlas; A J Hsueh
Journal:  Endocrinology       Date:  1996-04       Impact factor: 4.736

9.  Targeted disruption of Pten in ovarian granulosa cells enhances ovulation and extends the life span of luteal cells.

Authors:  Heng-Yu Fan; Zhilin Liu; Nicola Cahill; JoAnne S Richards
Journal:  Mol Endocrinol       Date:  2008-07-07

10.  Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.

Authors:  Michael S Anglesio; Jeremy M Arnold; Joshy George; Anna V Tinker; Richard Tothill; Nic Waddell; Lisa Simms; Bianca Locandro; Sian Fereday; Nadia Traficante; Peter Russell; Raghwa Sharma; Michael J Birrer; Anna deFazio; Georgia Chenevix-Trench; David D L Bowtell
Journal:  Mol Cancer Res       Date:  2008-11       Impact factor: 5.852

View more
  216 in total

Review 1.  Local signalling environments and human male infertility: what we can learn from mouse models.

Authors:  Roopa L Nalam; Martin M Matzuk
Journal:  Expert Rev Mol Med       Date:  2010-05-11       Impact factor: 5.600

Review 2.  Epigenetic effects of endocrine-disrupting chemicals on female reproduction: an ovarian perspective.

Authors:  Aparna Mahakali Zama; Mehmet Uzumcu
Journal:  Front Neuroendocrinol       Date:  2010-07-04       Impact factor: 8.606

3.  A new hypothesis regarding ovarian follicle development: ovarian rigidity as a regulator of selection and health.

Authors:  Teresa K Woodruff; Lonnie D Shea
Journal:  J Assist Reprod Genet       Date:  2010-09-25       Impact factor: 3.412

4.  Geography of follicle formation in the embryonic mouse ovary impacts activation pattern during the first wave of folliculogenesis.

Authors:  Marília H Cordeiro; So-Youn Kim; Katherine Ebbert; Francesca E Duncan; João Ramalho-Santos; Teresa K Woodruff
Journal:  Biol Reprod       Date:  2015-08-05       Impact factor: 4.285

5.  Gene expression profiling of bovine ovarian follicular and luteal cells provides insight into cellular identities and functions.

Authors:  Sarah M Romereim; Adam F Summers; William E Pohlmeier; Pan Zhang; Xiaoying Hou; Heather A Talbott; Robert A Cushman; Jennifer R Wood; John S Davis; Andrea S Cupp
Journal:  Mol Cell Endocrinol       Date:  2016-09-28       Impact factor: 4.102

6.  Current and Futuristic Roadmap of Ovarian Cancer Management: An Overview.

Authors:  Orlandric Miree; Sanjeev Kumar Srivastava; Santanu Dasgupta; Seema Singh; Rodney Rocconi; Ajay Pratap Singh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.

Authors:  Ankur K Nagaraja; Chad J Creighton; Zhifeng Yu; Huifeng Zhu; Preethi H Gunaratne; Jeffrey G Reid; Emuejevoke Olokpa; Hiroaki Itamochi; Naoto T Ueno; Shannon M Hawkins; Matthew L Anderson; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2010-01-15

8.  Edaravone mitigates hexavalent chromium-induced oxidative stress and depletion of antioxidant enzymes while estrogen restores antioxidant enzymes in the rat ovary in F1 offspring.

Authors:  Jone A Stanley; Kirthiram K Sivakumar; Joe A Arosh; Robert C Burghardt; Sakhila K Banu
Journal:  Biol Reprod       Date:  2014-05-07       Impact factor: 4.285

Review 9.  Regulation of the ovarian reserve by members of the transforming growth factor beta family.

Authors:  Stephanie A Pangas
Journal:  Mol Reprod Dev       Date:  2012-09-11       Impact factor: 2.609

10.  Death domain-associated protein DAXX promotes ovarian cancer development and chemoresistance.

Authors:  Wei-Wei Pan; Jian-Jie Zhou; Xiao-Man Liu; Ying Xu; Lian-Jun Guo; Chao Yu; Qing-Hua Shi; Heng-Yu Fan
Journal:  J Biol Chem       Date:  2013-03-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.